{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":44,"n_cols":5,"rows_kept":44,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[14,2,14,3],[18,2,18,3],[18,4,18,5],[19,2,19,3],[19,4,19,5],[20,2,20,3],[20,4,20,5],[21,2,21,3],[22,2,22,3],[26,2,26,3],[27,2,27,3],[28,2,28,3],[36,2,36,3],[37,2,37,3],[41,2,41,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910830340303321"]
[null,null,"Autore",null,"Eichstadt Forsythe Lauren R."]
[null,null,"Titolo",null,"Drug compounding for veterinary professionals / / Lauren R. Eichstadt Forsythe, Alexandria E. Gochenauer"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, NJ : , : John Wiley & Sons, Inc., , [2023]"]
[{"$nulls":4},"©2023"]
[null,null,"ISBN",null,"1-119-76499-8"]
[{"$nulls":4},"1-119-76497-1"]
[null,null,"Descrizione fisica",null,"1 online resource (174 pages)"]
[null,null,"Disciplina",null,"636.08951"]
[null,null,"Soggetti",null,"Veterinary drugs"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Cover -- Title Page -- Copyright Page -- Contents -- Foreword -- Preface -- List of Acronyms -- About the Companion Website -- Introduction -- Chapter 1 Compounding Regulations -- Organizations and Regulatory Agencies Involved with Compounding -- Food and Drug Administration -- United States Pharmacopeia -- Drug Enforcement Administration -- State Boards of Pharmacy -- State Veterinary Boards -- Compliance Policy Guides and Guidance for Industry Documents -- What Is Compounding? -- The Food, Drug, and Cosmetic Act -- Animal Medicinal Drug Use Clarification Act -- Preparing Compounds from an Approved Product or a Pure Drug Powder -- Federal Versus State Law [8] -- Office Use Compounding -- Drug Quality and Security Act [26] -- Finding Additional Information -- References -- Chapter 2 Risk-Benefit Analysis of Compounded Medications -- Benefits of Compounded Products -- Dosage Form -- Flavoring -- Dosage Strength -- Eliminating Ingredients -- Availability Issues -- Appropriate Use of Compounded Medications -- FDA-Approved Drugs -- Compounded Medication Risks -- Compounded (USP) Versus Manufactured (cGMP) -- Risks Associated with Compounded Medications - A Look at the Literature -- Studies Showing Incorrect Potency -- Studies Showing Lack of Stability -- Studies Showing Lack of Efficacy -- Risks Associated with Specific Types of Compounds -- Active Ingredient Source Decisions -- Patient-Specific Compounding Versus Office Use Compounding -- Adverse Event Reporting -- Identifying Potential Formulation Issues -- Drugs Recalls -- Selecting a Compounding Pharmacy -- Client Education -- Reducing Risk "]
[{"$nulls":4},"in Practice -- Conclusion -- References -- Chapter 3 Beyond-Use Dating -- Factors Considered When Assigning BUDs and Expiration Dates -- USP Default BUDs -- Stability Studies -- Evaluating Stability Studies -- Determining BUDs for In-House Formulations."]
[{"$nulls":4},"BUD Considerations When Prescribing Compounded Medications -- Conclusion -- References -- Chapter 4 Identifying High-Quality Compounding Pharmacies -- Case Study 1 -- Case Study 2 -- What to Evaluate -- General Practices -- Staff Skill Level -- Familiarity with Veterinary Medicine -- Pharmacy Culture -- Ways to Evaluate Compounding Pharmacies -- Looking Beyond the Pharmacy's Website -- What to Look for on a Tour -- Questions to Ask the Pharmacist in Charge -- Conclusion -- References -- Chapter 5 Formulation Development -- Dosage Forms -- Oral Administration -- Transdermal Administration -- Topical Administration -- Otic Administration -- Other Routes of Administration -- Ingredients -- Organic Salts -- Inorganic Salts -- Oral Liquid Medications -- Oral Solid Medications -- Emulsions -- Transdermal Medications -- Cream, Gel, and Ointment Medications -- Hazardous Drugs -- Beyond-Use Dates -- Formulation Resources -- Calculations -- Measurements Used in Compounding -- Displacement Factor -- Capsules: Packing Statistics -- Packing Statistic of Drug -- Average Weight of Ingredients -- Percentage of Drug per Capsule Using Bulk Powder -- Percentage of Drug per Capsule Using Manufactured Tablet -- Percentage/Amount of Filler per Capsule -- Conversion to Grams -- Compounding Formulations to Avoid -- Formulation Development Process -- Developing a Compounding Formula: Example 1 (USP Compounding Compendium) -- Developing a Compounding Formula: Example 2 (Stability-Indicating Assay) -- Compounding Formulation Assessment -- References -- Chapter 6 Compounding in House -- Documentation -- Master Formulation Record -- Compounding Record -- Formulation Record Components -- Quality Assurance and Quality Control -- Labeling -- Packaging and Storage -- Compounding Techniques -- Trituration -- Sifting -- Geometric Dilution -- Wetting -- Colored Tracers -- Equipment."]
[{"$nulls":4},"Mortars and Pestles -- Glassware -- Containers -- Scales -- Spatulas and Measuring Devices -- Equipment Cleaning -- Training -- Formulation Instructions -- Species-Specific Information -- Flavoring -- Toxicities -- Potency Designations -- Feasibility for a Veterinary Clinic -- References -- Index -- EULA."]
[null,"2.","Record Nr.",null,"UNINA9910963335003321"]
[null,null,"Autore",null,"Eisenstadt Abraham Seldin <1920->"]
[null,null,"Titolo",null,"Carnegie's model republic : Triumphant democracy and the British-American relationship / / A.S. Eisenstadt"]
[null,null,"Pubbl/distr/stampa",null,"Albany, : State University of New York Press, c2007"]
[null,null,"ISBN",null,"9780791479384"]
[{"$nulls":4},"0791479382"]
[{"$nulls":4},"9781435606487"]
[{"$nulls":4},"1435606485"]
[null,null,"Descrizione fisica",null,"1 online resource (222 p.)"]
[null,null,"Disciplina",null,"973.5"]
[null,null,"Soggetti",null,"National characteristics, American"]
[{"$nulls":4},"National characteristics, British"]
[{"$nulls":4},"Great Britain Civilization"]
[{"$nulls":4},"Great Britain Relations United States"]
[{"$nulls":4},"United States Economic conditions 1865-1918"]
[{"$nulls":4},"United States Politics and government 1865-1900"]
[{"$nulls":4},"United States Relations Great Britain"]
[{"$nulls":4},"United States Social life and customs 1865-1918"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 179-197) and index."]
[null,null,"Nota di contenuto",null,"Front Matter -- Contents -- Acknowledgments -- Introduction -- The Road to Triumphant Democracy -- Major Themes -- The Antithesis of Models -- Reconciling Ideals -- The British Critique -- Affirming America -- The Pan-Anglian Persuasion -- Conclusion -- Notes -- A Brief Note on Sources -- Index"]
[null,null,null,"Sommario/riassunto","Andrew Carnegie (1835–1919) has long been known as a leading American industrialist, a man of great wealth and great philanthropy. What is not as well known is that he was actively involved in Anglo-American politics and tried to promote a closer relationship between his native Britain and the United States. To that end, Carnegie published Triumphant Democracy in 1886, in which he proposed the American federal republic as a model for solving Britain's unsettling problems. On the basis of his own experience, Carnegie argued that America was a much-improved Britain and that the British monarchy could best overcome its social and political turbulence by following the "]
[{"$nulls":4},"democratic American model. He expressed a growing belief that the antagonism between the two nations should be supplanted by rapprochement. A. S. Eisenstadt offers an in-depth analysis of Triumphant Democracy, illustrating its importance and illuminating the larger current of British-American politics between the American Revolution and World War I and the fascinating exchange about the virtues and defects of the two nations."]